Theilmeier G et al. |
High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. |
2006 |
Circulation |
pmid:16982942
|
Jin ZQ et al. |
Sphingosine kinase activation mediates ischemic preconditioning in murine heart. |
2004 |
Circulation |
pmid:15451787
|
Yang J et al. |
Proximal cerebral arteries develop myogenic responsiveness in heart failure via tumor necrosis factor-α-dependent activation of sphingosine-1-phosphate signaling. |
2012 |
Circulation |
pmid:22668972
|
Levkau B et al. |
High-density lipoprotein stimulates myocardial perfusion in vivo. |
2004 |
Circulation |
pmid:15545521
|
Meissner A et al. |
Tumor necrosis factor-α-mediated downregulation of the cystic fibrosis transmembrane conductance regulator drives pathological sphingosine-1-phosphate signaling in a mouse model of heart failure. |
2012 |
Circulation |
pmid:22534621
|
Bolz SS et al. |
Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway. |
2003 |
Circulation |
pmid:12796138
|
Augé N et al. |
Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. |
2004 |
Circulation |
pmid:15277330
|
Kikuta J et al. |
[Encounter of cancer cells with bone. In vivo imaging of osteoclasts and their precursors in intact bone tissues]. |
2011 |
Clin Calcium |
pmid:21358058
|
Kotani M et al. |
[Bone and calcium update; bone research update. Trafficking of osteoclast precursors visualized by intravital imaging technology]. |
2011 |
Clin Calcium |
pmid:22133828
|
Ohkawa R et al. |
Possible involvement of sphingomyelin in the regulation of the plasma sphingosine 1-phosphate level in human subjects. |
2015 |
Clin. Biochem. |
pmid:25863111
|
Bekpinar S et al. |
The effect of nephropathy on plasma sphingosine 1-phosphate concentrations in patients with type 2 diabetes. |
2015 |
Clin. Biochem. |
pmid:26255120
|
Murph M et al. |
Of spiders and crabs: the emergence of lysophospholipids and their metabolic pathways as targets for therapy in cancer. |
2006 |
Clin. Cancer Res. |
pmid:17121877
|
Zhang L et al. |
Anti-S1P Antibody as a Novel Therapeutic Strategy for VEGFR TKI-Resistant Renal Cancer. |
2015 |
Clin. Cancer Res. |
pmid:25589614
|
Dickson MA et al. |
A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors. |
2011 |
Clin. Cancer Res. |
pmid:21257722
|
Beider K et al. |
The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 Pathway. |
2017 |
Clin. Cancer Res. |
pmid:27697999
|
Scherer M et al. |
High-throughput analysis of sphingosine 1-phosphate, sphinganine 1-phosphate, and lysophosphatidic acid in plasma samples by liquid chromatography-tandem mass spectrometry. |
2009 |
Clin. Chem. |
pmid:19325012
|
Ikeda H et al. |
Plasma concentration of bioactive lipid mediator sphingosine 1-phosphate is reduced in patients with chronic hepatitis C. |
2010 |
Clin. Chim. Acta |
pmid:20188085
|
Ren K et al. |
Apolipoprotein M. |
2015 |
Clin. Chim. Acta |
pmid:25858547
|
Liu X et al. |
ABCA1, ABCG1, and SR-BI: Transit of HDL-associated sphingosine-1-phosphate. |
2012 |
Clin. Chim. Acta |
pmid:22115863
|
Mirzaian M et al. |
Accurate quantification of sphingosine-1-phosphate in normal and Fabry disease plasma, cells and tissues by LC-MS/MS with (13)C-encoded natural S1P as internal standard. |
2016 |
Clin. Chim. Acta |
pmid:27221202
|
Ceglarek U et al. |
Preanalytical standardization of sphingosine-1-phosphate, sphinganine-1-phosphate and sphingosine analysis in human plasma by liquid chromatography-tandem mass spectrometry. |
2014 |
Clin. Chim. Acta |
pmid:24768784
|
Moritz E et al. |
Reference intervals for serum sphingosine-1-phosphate in the population-based Study of Health in Pomerania. |
2017 |
Clin. Chim. Acta |
pmid:28159438
|
Jing XD et al. |
The relationship between the high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P) and coronary in-stent restenosis. |
2015 |
Clin. Chim. Acta |
pmid:25958848
|
Moriue T et al. |
Sphingosine 1-phosphate attenuates peroxide-induced apoptosis in HaCaT cells cultured in vitro. |
2013 |
Clin. Exp. Dermatol. |
pmid:23837937
|
Tanaka K et al. |
Anti-interleukin-6 receptor antibody prevents systemic bone mass loss via reducing the number of osteoclast precursors in bone marrow in a collagen-induced arthritis model. |
2014 |
Clin. Exp. Immunol. |
pmid:24028747
|
Benaud CM et al. |
Deregulated activation of matriptase in breast cancer cells. |
2002 |
Clin. Exp. Metastasis |
pmid:12498394
|
Ishizawa S et al. |
Sphingosine-1-phosphate induces differentiation of cultured renal tubular epithelial cells under Rho kinase activation via the S1P2 receptor. |
2014 |
Clin. Exp. Nephrol. |
pmid:24463961
|
Kee TH et al. |
Sphingosine kinase signalling in immune cells. |
2005 |
Clin. Exp. Pharmacol. Physiol. |
pmid:15743396
|
Rana A and Sharma S |
Mechanism of sphingosine-1-phosphate induced cardioprotection against I/R injury in diabetic rat heart: Possible involvement of glycogen synthase kinase 3β and mitochondrial permeability transition pore. |
2016 |
Clin. Exp. Pharmacol. Physiol. |
pmid:26582369
|
Yaghobian D et al. |
Increased sphingosine 1-phosphate mediates inflammation and fibrosis in tubular injury in diabetic nephropathy. |
2016 |
Clin. Exp. Pharmacol. Physiol. |
pmid:26414003
|
Garg SK et al. |
Does sphingosine 1-phosphate play a protective role in the course of pulmonary tuberculosis? |
2006 |
Clin. Immunol. |
pmid:17049310
|
Mao-Draayer Y et al. |
The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases. |
2017 |
Clin. Immunol. |
pmid:27890706
|
Yokoyama K et al. |
Decrease of serum sphingosine-1-phosphate levels in hemodialysis patients with secondary hyperparathyroidism treated with cinacalcet. |
2012 |
Clin. Nephrol. |
pmid:22732343
|
Roviezzo F et al. |
Involvement of proteinase activated receptor-2 in the vascular response to sphingosine 1-phosphate. |
2014 |
Clin. Sci. |
pmid:24131465
|
Selim S et al. |
Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions. |
2011 |
Clin. Sci. |
pmid:21749329
|
Anderson G and Maes M |
Reconceptualizing adult neurogenesis: role for sphingosine-1-phosphate and fibroblast growth factor-1 in co-ordinating astrocyte-neuronal precursor interactions. |
2014 |
CNS Neurol Disord Drug Targets |
pmid:24040808
|
Leo A et al. |
The Sphingosine 1-Phosphate Signaling Pathway in Epilepsy: A Possible Role for the Immunomodulator Drug Fingolimod in Epilepsy Treatment. |
2017 |
CNS Neurol Disord Drug Targets |
pmid:27823573
|
Vanoli E et al. |
Vagomimetic effects of fingolimod: physiology and clinical implications. |
2014 |
CNS Neurosci Ther |
pmid:24836740
|
Van Brocklyn JR and Williams JB |
The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death. |
2012 |
Comp. Biochem. Physiol. B, Biochem. Mol. Biol. |
pmid:22613819
|
Nelson CJ et al. |
Global analysis of circulating metabolites in hibernating ground squirrels. |
2010 |
Comp. Biochem. Physiol. Part D Genomics Proteomics |
pmid:20728417
|
Babahosseini H et al. |
Roles of bioactive sphingolipid metabolites in ovarian cancer cell biomechanics. |
2012 |
Conf Proc IEEE Eng Med Biol Soc |
pmid:23366417
|
Barnawi J et al. |
Pro-phagocytic Effects of Thymoquinone on Cigarette Smoke-exposed Macrophages Occur by Modulation of the Sphingosine-1-phosphate Signalling System. |
2016 |
COPD |
pmid:27144721
|
Sugiura T et al. |
Analytical evaluation of plasma serotonin and sphingosine 1-phosphate and their clinical assessment in early atherosclerosis. |
2012 |
Coron. Artery Dis. |
pmid:22356865
|
Ito S et al. |
TNF-α production in NKT cell hybridoma is regulated by sphingosine-1-phosphate: implications for inflammation in atherosclerosis. |
2014 |
Coron. Artery Dis. |
pmid:24448174
|
Ito S et al. |
Increased plasma sphingosine-1-phosphate in obese individuals and its capacity to increase the expression of plasminogen activator inhibitor-1 in adipocytes. |
2013 |
Coron. Artery Dis. |
pmid:24212262
|
Winkler MS et al. |
Decreased serum concentrations of sphingosine-1-phosphate in sepsis. |
2015 |
Crit Care |
pmid:26498205
|
Egom EE et al. |
Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy. |
2013 May-Jun |
Crit Rev Clin Lab Sci |
pmid:23885725
|
Barth BM et al. |
Gaucher's disease and cancer: a sphingolipid perspective. |
2013 |
Crit Rev Oncog |
pmid:23510065
|
Altay O et al. |
Isoflurane delays the development of early brain injury after subarachnoid hemorrhage through sphingosine-related pathway activation in mice. |
2012 |
Crit. Care Med. |
pmid:22488000
|
Rohrbach T et al. |
Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology. |
2017 |
Crit. Rev. Biochem. Mol. Biol. |
pmid:28618839
|